Moreover, a large‐scale biomarker study in AD patients with combined amyloid‐PET, tau‐PET, and TSPO‐PET for assessing microglial activation levels could show that elevated microglial activation may promote the aggregation and spreading of fibrillary tau deposits (Pascoal et al, 2021). This evidence concerns the gene MAPT and Alzheimer disease.